Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074 and Exploration of Effects on Potential Markers of Clinical Efficacy in Patients With Mild Cognitive Impairment - Prolonged Open Label Extension Phase
Clinical trial NCT01602393 · COMPLETED
Trial details
- NCT number
- NCT01602393
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2013-10-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.